Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a note issued to investors on Monday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Up 1.1 %

Shares of ENZ stock opened at $0.43 on Monday. Enzo Biochem has a 12-month low of $0.41 and a 12-month high of $1.30. The stock’s 50-day moving average price is $0.53 and its 200-day moving average price is $0.83.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings data on Monday, March 17th. The medical research company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $7.33 million during the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Investors Weigh In On Enzo Biochem

Hedge funds have recently bought and sold shares of the business. Virtu Financial LLC purchased a new position in shares of Enzo Biochem in the 4th quarter worth $35,000. Lepercq Multi Asset Fund bought a new position in shares of Enzo Biochem in the 4th quarter valued at about $88,000. Wittenberg Investment Management Inc. lifted its holdings in shares of Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after acquiring an additional 70,400 shares during the last quarter. Geode Capital Management LLC grew its position in Enzo Biochem by 3.3% in the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after acquiring an additional 11,742 shares in the last quarter. Finally, Mink Brook Asset Management LLC bought a new stake in Enzo Biochem during the fourth quarter worth approximately $577,000. Hedge funds and other institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.